Navigation Links
How cells running on empty trigger fuel recycling
Date:12/23/2010

LA JOLLA, CAResearchers at the Salk Institute for Biological Studies have discovered how AMPK, a metabolic master switch that springs into gear when cells run low on energy, revs up a cellular recycling program to free up essential molecular building blocks in times of need.

In a paper published in the Dec. 23, 2010 edition of Science Express, a team led by Reuben Shaw, PhD., Howard Hughes Medical Institute Early Career Scientist and Hearst Endowment assistant professor in the Salk's Molecular and Cell Biology Laboratory, reports that AMPK activates a cellular recycling process known as autophagy by activating an enzyme known as ATG1, that jumpstarts the process.

The newly uncovered direct molecular connection between AMPK and ATG1 is significant because dysfunctions in both AMPK signaling and autophagy are implicated in a plethora of aging-related diseases, including type II diabetes, cancer, and neurodegenerative diseases such Parkinson's and Alzheimers.

Despite its ominous namederived from "self" (auto) and "eating" (phagy)cells use autophagy to dispose of debris before it becomes toxic enough to kill a cell. "Autophagy is an ancient process that evolved to break down components cells don't need to create things they do need," says Dan Egan, a graduate student in Shaw's lab and the study's first author.

Previously, Shaw's lab had not only demonstrated that AMPK is deregulated in certain forms of cancer but also that the enzyme is a critical target of the type 2 diabetes drug metformin. "Taking a drug that activates this pathway, like metformin, is the equivalent of taking several different drugs," says Shaw, reeling off a list of anti-tumor and anti-diabetes pathways activated by AMPK. "Now we can add regulation of autophagy to that list."

Shaw's laboratory has not previously studied autophagy but has had a long-term interest in AMPK, which senses when energy is low and slows cell growth. "Since AMPK plays such a central role in regulating our cells' energy household, we wanted to know how it exerts its power over so many cellular processes," says Shaw.

His team initiated the study by defining a unique targeting sequence used by AMPK to transmit its signals and then using bioinformatics and biochemistry to identify proteins that act as AMPK targets. One of the prime suspects identified in that that effort was the protein Atg1/ULK1, a factor that triggers autophagy in yeast.

To test the effects on autophagy of deregulating these enzymes, the group focused on large intracellular structures called mitochondria, whose role is to generate energy. "Mitochondria are easily damaged in detoxifying tissues like liver," explains Shaw. "A critical way that defective mitochondria are turned over is through a special form of autophagy called mitophagy."

In that case, cells would envelope their unhealthy mitochondria in a membrane, dump them in a cellular acid pit, and recycle the remains. If AMPK initiated the process, cells genetically engineered to lack AMPK might show altered mitochondrial turnover compared to normal cells.

And that is precisely what the researchers saw: liver cells in which AMPK had been eliminated contained too many mitochondria, many of which looked spindly, indicating they were moribund, and confirming that AMPK was directing autophagic waste disposal. "We found that the ability to recycle their defective mitochondria allowed cells to survive starvation better," says Shaw.

To tie it all together, the researchers used the roundworm C. elegans, a popular model system in aging research, to show that activated AMPK directly activated autophagy through a signal relayed by the worm version of Atg1/ULK1experiments done in collaboration with Malene Hansen, Ph.D., of La Jolla's Sanford-Burnham Medical Research Institute and with help from Andy Dillin, Ph.D., of Salk's Molecular and Cell Biology Laboratory,

"The worm experiments show that the connection between AMPK, ULK1 and autophagy is conserved across evolution and not just a recent adaptation specific to mammals," says Egan. "Processes fundamental to life, like energy regulation, metabolism and autophagy, share components across human, mouse, worm, and yeast species."

But if you aren't an evolutionary biologist, you still have a personal stake in AMPK signaling if you: exercise regularly, feel good about drinking red wine, take diabetes meds, and/or starve yourself in hopes of a long lifeall of which reportedly stimulate AMPK signals.

Add to that the possibility that AMPK may have anti-tumor activity and it is no wonder that pharmaceutical companies are keenly interested in what proteins AMPK "talks to" and how drugs that stimulate that conversation work.


'/>"/>

Contact: Gina Kirchweger
kirchweger@salk.edu
858-453-4100 x1340
Salk Institute
Source:Eurekalert  

Related medicine news :

1. UCLA researchers uncover new cell biological mechanism that regulates protein stability in cells
2. Cancer Cells May Be Able to Urge Their Own Death
3. Tumor cells in blood may signal worse prognosis in head and neck cancer patients
4. Finnish researchers find a compound that prevents the growth of prostate cancer cells
5. UCSF team finds new source of immune cells during pregnancy
6. Protein disables p53, drives breast cells toward cancer transition
7. Human umbilical cord blood cells found to enhance survival and maturation of key brain cells
8. The stemness of cancer cells
9. Sperm-Producing Cells Coaxed to Produce Insulin
10. Researchers Turn Stem Cells Into Intestinal Tissue in Lab
11. Stray Breast Tumor Cells in Early Chemo Could Be Bad Sign
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
How cells running on empty trigger fuel recycling
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... ... gather at Boston CEO 2017 on May 30th and 31st at The Four ... forum for leading executives in the life sciences, offering exclusive access to key ...
(Date:5/26/2017)... ... 26, 2017 , ... Amir Qureshi, MD is the first physician in Arkansas ... stimulation system. The Nuvectra™ Algovita SCS System has been FDA approved as a treatment ... in Arkansas to introduce the most powerful SCS system and the only stretchable lead ...
(Date:5/26/2017)... ... , ... A new analysis of community health data reveals that four out ... Midwest. With the average cost of healthcare rising and the U.S. senior population expected ... and affordability of where they live. An annual 2017 report looked at a variety ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... ever copper, antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. ... “We are thrilled to partner with Cupron® to provide customers with a game ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... After raising ... Antzy Top gadget will continue to be available at a discounted crowdfunding price on ... with stress wherever they are, I also wanted to bring a fidget toy to ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... it has earned a spot on Forbes, ... was ranked among 500 U.S. employers as well as ... and Services. The annual Forbes ... survey of over 30,000 employees across 25 industries. The ...
(Date:5/9/2017)... 9, 2017  Semler Scientific, Inc. (OTCQB: SMLR), ... to improve the clinical effectiveness and efficiency of ... first quarter ended March 31, 2017. ... customers to identify when preventive care options are ... like heart attacks or strokes occur," said ...
(Date:5/6/2017)... Texas , May 5, 2017   Provista , ... with more than 200,000 customers, today announced Jim Cunniff ... a wealth of executive and business experience to Provista, including ... compounding pharmacy in California . He assumed ... "Jim is a great fit for Provista," says ...
Breaking Medicine Technology: